Kaimax 200unit: A Professional Guide to Sourcing and Product Specifications

Kaimax 200unit represents a specific dosage presentation within the range of botulinum toxin type A products. Manufactured by Jetema, a South Korean pharmaceutical company, it is recognized in professional aesthetic markets for its defined unit count. For clinics evaluating their neurotoxin inventory, understanding products like Kaimax 200unit is crucial for efficient stock management and treatment planning. The selection of a specific unit presentation often aligns with typical patient needs or clinic protocols, offering flexibility alongside other formulations.

Kaimax 200unit is typically supplied as a lyophilized powder for reconstitution. Each vial contains 200 units of Clostridium botulinum toxin type A, along with excipients such as human serum albumin and sodium chloride, which stabilize the active ingredient. The product is designed for professional reconstitution with a sterile, non-preserved saline solution before use. This standardized presentation ensures consistency and supports precise dosing for various aesthetic and therapeutic applications in a professional setting. Similar presentations can be found across the wider botulinum toxin / neurotoxin catalog sourced by clinics.

For aesthetic professionals, Kaimax 200unit is indicated for temporary improvement in the appearance of moderate to severe glabellar lines, lateral canthal lines, and forehead lines associated with corrugator and/or procerus muscle activity. Beyond facial aesthetics, botulinum toxins are routinely considered for a range of therapeutic applications, including the management of muscle spasticity or hyperhidrosis. The 200-unit vial offers flexibility for clinics managing higher volume needs or treating multiple areas within a single session, or for practices that prefer to reconstitute larger quantities for efficiency. Products like Re N Tox 200unit and Nabota 200unit offer comparable unit options within the market.

The duration of effect for botulinum toxin type A products like Kaimax 200unit is typically described in professional literature as lasting several months, commonly ranging from three to six months. This timeframe can vary based on individual patient metabolism, injection technique, dosage, and the specific area treated. For clinics, this information is vital for patient education and planning follow-up appointments, ensuring a consistent patient experience. It is important for practitioners to manage patient expectations regarding the expected duration, emphasizing that individual responses can differ.

Acquiring Kaimax 200unit involves careful consideration of supplier reliability and product integrity. Professionals prioritize sourcing from distributors that ensure authentic products with transparent supply chains. Volume purchasing can often lead to more favorable terms, which is a key consideration for clinics managing regular demand. When selecting a supplier, evaluate their capability to provide product documentation, including lot numbers and expiration dates, which are essential for inventory tracking and regulatory compliance.

Wholesale pricing for Kaimax 200unit is structured to benefit professional buyers based on purchase volume. For illustrative purposes, a baseline unit price might be established, with increasing discounts applied at specific quantity thresholds. For example, an illustrative unit price of $92.2 could see tiered discounts: 11-20 units receive 4% off, 21-30 units receive 5% off, 31-50 units receive 6% off, and orders of 51+ units receive 8% off. These volume tiers allow clinics to optimize procurement costs. For further market context on sourcing strategies, professionals might consult resources like the Kairax Filler Alternatives: A Professional Comparison for Aesthetics guide.

Maintaining the integrity of Kaimax 200unit requires strict adherence to cold chain protocols from shipment to storage within the clinic. The product must be stored under specific refrigerated conditions, typically between 2-8°C, to ensure its stability and potency until the moment of reconstitution. Distributors are responsible for maintaining this temperature range during transit, and clinics must implement appropriate storage solutions upon receipt. Proper cold chain management is non-negotiable for preserving the active components of botulinum toxin products.